Details for New Drug Application (NDA): 211848
✉ Email this page to a colleague
The generic ingredient in TAVABOROLE is tavaborole. There are six drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the tavaborole profile page.
Summary for 211848
Tradename: | TAVABOROLE |
Applicant: | Padagis Us |
Ingredient: | tavaborole |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Pharmacology for NDA: 211848
Mechanism of Action | Protein Synthesis Inhibitors |
Suppliers and Packaging for NDA: 211848
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
TAVABOROLE | tavaborole | SOLUTION;TOPICAL | 211848 | ANDA | Padagis US LLC | 0574-0157 | 0574-0157-10 | 1 BOTTLE, GLASS in 1 CARTON (0574-0157-10) / 10 mL in 1 BOTTLE, GLASS |
TAVABOROLE | tavaborole | SOLUTION;TOPICAL | 211848 | ANDA | Bryant Ranch Prepack | 63629-8704 | 63629-8704-1 | 1 BOTTLE, GLASS in 1 CARTON (63629-8704-1) / 10 mL in 1 BOTTLE, GLASS |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION;TOPICAL | Strength | 5% | ||||
Approval Date: | Oct 13, 2020 | TE: | AB | RLD: | No |
Complete Access Available with Subscription